ALACRIS CMTA

Serial Number 98027963
730

Registration Progress

Application Filed
Jun 5, 2023
Under Examination
Sep 3, 2024
Approved for Publication
Jul 9, 2024
Published for Opposition
Jul 9, 2024
Registered

Trademark Image

ALACRIS CMTA

Basic Information

Serial Number
98027963
Filing Date
June 5, 2023
Published for Opposition
July 9, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Feb 25, 2025
Application
Pending
Classes
005 042 044

Rights Holder

Alacris Theranostics GmbH

99
Address
Max-Planck-Str. 3
Berlin 12489
DE

Ownership History

Alacris Theranostics GmbH

Original Applicant
99
Berlin DE

Alacris Theranostics GmbH

Owner at Publication
99
Berlin DE

Legal Representation

Attorney
Gregory Turocy

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

19 events
Date Code Type Description Documents
Aug 21, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Feb 26, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 25, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 25, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 25, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 3, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 9, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 9, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 19, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 30, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 29, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 29, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 29, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 5, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 5, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 5, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 26, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 9, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 8, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Diagnostic preparations and substances for medical purposes; Biological reagents for medical use; Chemical preparations for testing blood for medical purposes; Chemical preparations for use in DNA analysis, namely medical; Chemical reagents for medical use; Chemical test reagents, namely medical; Clinical diagnostic reagents for medical purposes; Clinical medical reagents; Diagnostic agents for medical use; Diagnostic agents for pharmaceutical use; Diagnostic biomarker reagents for medical purposes; Diagnostic chemical reagents for medical use; Diagnostic preparations for medical purposes; Diagnostic reagents for medical use; Diagnostic substances for medical use; Diagnostic testing materials for medical use, namely, medical diagnostic test media for gene sequencing of tumor samples, medical diagnostic test media for gene sequencing of blood samples, and medical diagnostic test media for gene sequencing of tissue samples; Immunoassay reagents for medical use; In vitro diagnostic preparations for medical use; Biological indicators for medical diagnosis; Medical diagnostic reagents and assays for testing of body fluids; Preparations for detecting genetic predispositions for medical purposes; preparations consisting of pre-mixed reactants for medical diagnosis; Reagents for analytical purposes, namely for medical purposes; Reagents for blood grouping, namely for medical purposes; Reagents for in-vitro laboratory use, namely for medical purposes; Reagents for use in analysis, namely for medical purposes; Reagents for use with analyzers, namely for medical purposes; Reagents for use in diagnostic tests, namely for medical purposes
Class 042
Analysis of human tissues for medical research; Research laboratory services in the field of cancer diagnostics; Scientific research for medical purposes in the area of cancerous diseases; Medical research laboratory services; Scientific investigations for medical purposes; Providing scientific information in the field of medical disorders and their treatment
Class 044
Advisory services relating to medical problems; Advisory services relating to medical services; Medical analysis of human serum for medical treatment purposes provided by medical laboratories; Medical analysis of human tissues for medical treatment purposes provided by medical laboratories; Breast cancer screening services; Bowel cancer screening services; Cervical cancer screening services; Collection and preservation of human blood; Compilation of medical reports, namely, providing medical information to patients in the form of reports in the field of molecular tumor analysis; Conducting of medical examinations; Health clinic services, namely medical; Genetic testing for medical purposes; DNA screening for medical purposes; Immunodetection services for medical purposes; Lung cancer screening services; Medical analysis services for cancer diagnosis and prognosis; Medical analysis services for the diagnosis of cancer; Medical analysis for the diagnosis and treatment of persons; Medical care and analysis services relating to patient treatment; Medical counseling; Medical diagnostic services; Medical screening; Medical services in the field of oncology; Medical services for the treatment of skin cancer; Medical services for the diagnosis of conditions of the human body; Medical laboratory services for the analysis of samples taken from patients for diagnostic and treatment purposes; Medical laboratory services for the analysis of blood samples taken from patients for diagnostic and treatment purposes; Medical testing for diagnostic or treatment purposes; Medical testing services relating to the diagnosis and treatment of disease; Providing cancer screening services; Prostate cancer screening services; Preparation of reports providing medical information to patients relating to medical matters in the field of cancer diagnosis; Public health counseling; Provision of medical services; RNA or DNA analysis for cancer diagnosis and prognosis; Services for the testing of blood for diagnostic and treatment purposes provided by medical laboratories; Services for the testing of sera for diagnostic and treatment purposes provided by medical laboratories; Services for the testing of urine for diagnostic and treatment purposes provided by medical laboratories; Testicular cancer screening services; Next generation sequencing of tumor and control samples for diagnostic and treatment purposes provided by medical laboratories; Bioinformatic analysis of next generation sequencing data for pan-cancer diagnostics, provided by medical laboratories

Classification

International Classes
005 042 044